These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25970755)

  • 21. Preliminary Experience with Conservative Sharp Wound Debridement by Nurses in the Outpatient Management of Diabetic Foot Ulcers: Safety, Efficacy, and Economic Analysis.
    Schumer RA; Guetschow BL; Ripoli MV; Phisitkul P; Gardner SE; Femino JE
    Iowa Orthop J; 2020; 40(1):43-47. PubMed ID: 32742207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost-effectiveness of a novel soluble beta-glucan gel.
    Cutting KF
    J Wound Care; 2017 May; 26(5):228-234. PubMed ID: 28475444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of becaplermin gel on wound healing of diabetic foot ulcers.
    Gilligan AM; Waycaster CR; Motley TA
    Wound Repair Regen; 2015; 23(3):353-60. PubMed ID: 25810233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The case for evidence in wound care: investigating advanced treatment modalities in healing chronic diabetic lower extremity wounds.
    Lyon KC
    J Wound Ostomy Continence Nurs; 2008; 35(6):585-90. PubMed ID: 19018198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of surgical debridement in healing of diabetic foot ulcers.
    Gordon KA; Lebrun EA; Tomic-Canic M; Kirsner RS
    Skinmed; 2012; 10(1):24-6. PubMed ID: 22324173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: neuropathic, ischemic, and neuro-ischemic type.
    Yotsu RR; Pham NM; Oe M; Nagase T; Sanada H; Hara H; Fukuda S; Fujitani J; Yamamoto-Honda R; Kajio H; Noda M; Tamaki T
    J Diabetes Complications; 2014; 28(4):528-35. PubMed ID: 24846054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of debridement and Vacuum-Assisted Closure (V.A.C.) Therapy in diabetic foot ulcers.
    Eneroth M; van Houtum WH
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S76-80. PubMed ID: 18393328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with surgical debridement and simultaneous meshed skin grafts in treating biofilm-associated infection: an exploratory retrospective pilot study.
    Namgoong S; Jung SY; Han SK; Kim AR; Dhong ES
    J Plast Surg Hand Surg; 2020 Feb; 54(1):47-54. PubMed ID: 31575315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical effects of application of antibiotic bone cement in wounds of diabetic foot ulcers].
    Huang HJ; Niu XH; Yang GL; Wang LY; Shi FC; Xu SJ; Xu LG; Li YL
    Zhonghua Shao Shang Za Zhi; 2019 Jun; 35(6):464-466. PubMed ID: 31280542
    [No Abstract]   [Full Text] [Related]  

  • 30. The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data.
    Persson U; Willis M; Odegaard K; Apelqvist J
    Value Health; 2000; 3 Suppl 1():39-46. PubMed ID: 16464208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries.
    Ghatnekar O; Willis M; Persson U
    J Wound Care; 2002 Feb; 11(2):70-4. PubMed ID: 11901743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial.
    Motley TA; Gilligan AM; Lange DL; Waycaster CR; Dickerson JE
    J Foot Ankle Res; 2015; 8():7. PubMed ID: 25767565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and economic benefit of enzymatic debridement of pressure ulcers compared to autolytic debridement with a hydrogel dressing.
    Waycaster C; Milne CT
    J Med Econ; 2013 Jul; 16(7):976-86. PubMed ID: 23701261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-utility of a biofilm-disrupting gel versus standard of care in chronic wounds: a Markov microsimulation model based on a randomised controlled trial.
    Carter MJ; Myntti MF
    J Wound Care; 2019 Jul; 28(Sup7):S24-S38. PubMed ID: 31295074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diabetic foot: the importance of biofilms and wound bed preparation.
    Davis SC; Martinez L; Kirsner R
    Curr Diab Rep; 2006 Dec; 6(6):439-45. PubMed ID: 17118226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wound care: biofilm and its impact on the latest treatment modalities for ulcerations of the diabetic foot.
    Kim PJ; Steinberg JS
    Semin Vasc Surg; 2012 Jun; 25(2):70-4. PubMed ID: 22817855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diabetic foot infections: biofilms and antimicrobial resistance.
    Malik A; Mohammad Z; Ahmad J
    Diabetes Metab Syndr; 2013; 7(2):101-7. PubMed ID: 23680250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds.
    Cardinal M; Eisenbud DE; Armstrong DG; Zelen C; Driver V; Attinger C; Phillips T; Harding K
    Wound Repair Regen; 2009; 17(3):306-11. PubMed ID: 19660037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical haemoglobin spray for diabetic foot ulceration.
    Bateman SD
    Br J Nurs; 2015 Jun 25-Jul 8; 24(12):S24-9. PubMed ID: 26110985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biofilms in chronic wounds.
    James GA; Swogger E; Wolcott R; Pulcini Ed; Secor P; Sestrich J; Costerton JW; Stewart PS
    Wound Repair Regen; 2008; 16(1):37-44. PubMed ID: 18086294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.